Efficacy and safety of intravenous OPC‐61815 compared with oral tolvaptan in patients with congestive heart failure

AIMS: This multicentre, randomized, controlled, double‐blind, parallel‐group Phase III study was conducted to confirm the non‐inferiority of OPC‐61815 (tolvaptan sodium phosphate) intravenous injections to oral tolvaptan tablets in patients with congestive heart failure and volume overload despite r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Naoki, Uno, Shingo, Kurita, Yuka, Kim, Seongryul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715865/
https://www.ncbi.nlm.nih.gov/pubmed/35794067
http://dx.doi.org/10.1002/ehf2.14021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715865/
https://www.ncbi.nlm.nih.gov/pubmed/35794067
http://dx.doi.org/10.1002/ehf2.14021

Ejemplares similares